Skip to main content


Important notice

Cancer Communications will cease to publish with BioMed Central on 31st December 2019. The journal is continuing in cooperation with a new publisher, Wiley starting from 2020. The new journal website is available at:

The current submission site will be inactive on 31st October 2019. Any new or revised manuscripts submitted after 1st November 2019 should go to the new site: Please contact the editorial office at for information regarding the new publisher and any submissions in progress.


Most accessed articles RSS

View all articles


Thematic series
Boron Neutron Capture Therapy of Cancer

Edited by Rolf F. Barth


Thematic series
Tumor Metastasis​​​​​​​
Edited by Jian Zhang and Chao-Nan Qian


Thematic series
Gastric Cancer
Edited by Yun Dai and Li Yan

Thematic series
Tumor Angiogenesis
Edited by Francesco Pezzella and Chao-Nan Qian


Thematic series
Lung Cancer
Edited by Lin Yan and Wei Zhang

Archival content

To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.

Thematic series

Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

Tumor metastasis
Edited by: Jian Zhang and Chao-Nan Qian

​​​​​​​Read more thematic series in Cancer Communications

Aims and scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.


Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Information for authors

Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.


Affiliated with

Annual Journal Metrics